Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Torsade de pointes associated with the use of intravenous haloperidol.

Literature DB >> 8338292

Torsade de pointes associated with the use of intravenous haloperidol.

J L Wilt, A M Minnema, R F Johnson, A M Rosenblum.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Haloperidol

Year: 1993 PMID： 8338292 DOI： 10.7326/0003-4819-119-5-199309010-00007

Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors: Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

Review 2. Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors: Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal: Drug Saf Date: 2005 Impact factor: 5.606

Review 3. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors: Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal: J Anesth Date: 2017-02-22 Impact factor: 2.078

4. A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.

Authors: Andrew J Muzyk; Sarah K Rivelli; Wei Jiang; Heather Heinz; Amber Rayfield; Jane P Gagliardi
Journal: Drug Saf Date: 2012-09-01 Impact factor: 5.606

5. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.

Authors: Andrew J Muzyk; Amber Rayfield; Jane Y Revollo; Heather Heinz; Jane P Gagliardi
Journal: Drug Saf Date: 2012-07-01 Impact factor: 5.606

6. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors: Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal: Circulation Date: 2010-02-08 Impact factor: 29.690

Review 7. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors: Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal: J Am Coll Cardiol Date: 2010-03-02 Impact factor: 24.094